US panel rejects routine use of BRCA cancer screening in womenBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2160 (Published 04 April 2013) Cite this as: BMJ 2013;346:f2160
- Michael McCarthy
Women whose family history does not suggest that they have an increased risk of carrying harmful BRCA1 and BRCA2 mutations should not undergo routine BRCA testing, according to draft recommendations released on 2 April by the US Preventive Services Task Force (USPSTF).1
Women whose family history suggests that they carry the cancer susceptibility genes should be tested but only after expert genetic counseling, the USPSTF panel said.
About 12.3% of women will develop breast cancer in their lifetime, and 2.8% will die from the disease. Clinically …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial